Here are relevant reports on : personalized-cosmetics-market
-
Personalized Medicine Market by Product (Personalized Medicine Testing, Personalized Medicine Therapeutics), Application (Oncology, Neurology, Cardiology) - Global Forecast to 2027
The global personalized medicine market is projected to reach USD ~500 billion by 2027 from USD 300 Billion in 2022, at a CAGR of 11% during the forecast period
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
SNP (Single Nucleotide Polymorphism) Market: Genotyping and Analysis, Future of SNPs in Personalized Medicine (2011-2016)
SNP (Single Nucleotide Polymorphism) genotyping is a measurement of genetic variations. It is the most common type of genetic variation between humans. Specific single base pair mutations are ideal for identifying correlation between genotype and human behavior.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Personalized Medicine (Biochips, SNP Genotyping) Competitive Analysis Market - 2019 By Types, Application & Geography
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Personalized Medicine (Biochips, SNP Genotyping)-Competitive Analysis Market - 2019 By Types, Application & Geography
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Halal Ingredients Market by Type (Ingredients for Food & Beverage Industry, Ingredients for Pharmaceutical Industry, Ingredients for Cosmetics Industry), Application (Food & Beverage, Pharmaceuticals, and Cosmetics), and Region - Global Forecast to 2025
The global halal ingredients market is estimated to be valued at USD 45.7 billion in 2019 and is projected to reach USD 64.8 billion by 2025, recording a CAGR of 6.0%. Consumption of food items is also increasing due to the surge in the Muslim population worldwide, which is projected to drive the growth of the halal ingredients market. Halal ingredients are also gaining traction in the healthcare and pharmaceutical industries due to the growing demand for dietary supplements and its health benefits. Consumers are witnessing an increasing demand for on-the-go, convenient, nutritionally enriched, and functional food & beverage products, due to their busy lifestyles. The growing trends of healthy snacking and increasing awareness about functional food & beverage products are also projected to drive the market for halal ingredients during the forecast period.Koninklijke DSM N.V. (Netherlands), Cargill (US), Barentz B.V. (Netherlands), ADM (US), Kerry (Ireland), DowDupont (US), Solvay S.A. (Belgium), BASF (Germany), Symrise (Germany), Ashland (US), Purecircle Limited (Malaysia), and Halagel (Malaysia).
- Published: June 2019
- Price: $ 4950
- TOC Available:
-
Pharmacogenomics Market by Product & Service (Kits & Reagents), Technology (Sequencing, PCR, Microarray), Application (Drug Discovery, Clinical Research, Personalized Medicine), Disease Area (Cancer, Neurological, Cardiovascular) - Global Forecast to 2028
The global pharmacogenomics market, valued at US$3.3 billion in 2022, stood at US$3.5 billion in 2023 and is projected to advance at a resilient CAGR of 10.6% from 2023 to 2028, culminating in a forecasted valuation of US$5.8 billion by the end of the period. The increasing focus on the translational approach to optimize drug development processes, increasing collaborations and partnerships between key players and research institutes, and rising incidence of cancer are the major driving factors of the pharmacogenomics market.
- Published: February 2024
- Price: $ 4950
- TOC Available:
-
Molecular Cytogenetics Market by Product (Kits, Reagents, Probes, Instrument, Software, Services), Technique (FISH, CISH, Comparative Genomic Hybridization [Array-based, Standard]), Application (Cancer, Personalized Medicine) - Global Forecast to 2030
The global molecular cytogenetics market, valued at US$0.97 billion in 2024, stood at US$1.02 billion in 2025 and is projected to advance at a resilient CAGR of 7.1% from 2024 to 2030, culminating in a forecasted valuation of US$1.43 billion by the end of the period. The market growth is fueled by increasing incidence of cancer & genetic disorders and rising usage of molecular cytogenetics in clinical pathology testing.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Human Organoids Market by Product (Liver, Kidney, Pancreatic Models (2D, 3D)), Disease Area (Oncology, GI, Neurological Disorders), Application (Drug Toxicity, Personalized Medicine), End User (Pharma & Biotech Companies, CROs) - Global Forecast to 2029
The global human organoids market, valued at US$1.07 billion in 2023, stood at US$1.19 billion in 2024 and is projected to advance at a resilient CAGR of 14.4% from 2024 to 2029, culminating in a forecasted valuation of US$2.33 billion by the end of the period. The main factor driving this market is the rising demand for organoids in drug testing, as they provide more reliable results than conventional 2D cell cultures.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Stem Cell Banking Market by Source (PSC, BMSC, ADSC, hESC, DPSC, NSC), Service Type (Sample Processing, Analysis, Collection, Storage), Application (Personalized Storage, Clinical (Autoimmune, Hematopoietic Disorders), Research) - Global Forecasts to 2023
The global stem cell banking market is projected to reach USD 9.30 Billion by 2023, at a CAGR of 8.2%. Major players in the global stem cell banking market include Cord Blood Registry (CBR) Systems (US), Cordlife Group Limited (Singapore), Cryo-Cell International (US), ViaCord (US), Cryo-Save AG (Netherlands), LifeCell International (India), StemCyte (US), Global Cord Blood Corporation (China), Smart Cells International (UK), Vita34 AG (Germany), and CryoHoldco (Mexico).
- Published: May 2018
- Price: $ 4950
- TOC Available:
-
Prescriptive Analytics Market by Component, Application (Customer Retention and Engagement and Personalized Recommendation), Deployment Mode, Organization Size, Vertical, Capability, and Region (2022 - 2026)
The prescriptive analytics market size is projected to reach USD 14.3 billion by 2026, at a Compound Annual Growth Rate (CAGR) of 24.0% during the forecast period. The major vendors in the global prescriptive analytics market include IBM (US), Microsoft (US), Salesforce (US), SAP (Germany), SAS Institute (US), Talend (US), FICO (US), Ayata (US), Altair (US), Alteryx (US), TIBCO (US), Sisense(US) Happiest Minds (India), Zebra (England), Infor (US), RapidMiner (US), Logi Analytics (US), Qlik (US), River Logic (US), Frontline Systems (US), Netformx (US), Mitek Analytics (France), and Panorat.IO (US).
- Published: November 2021
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
